Arguing for Adaptive Clinical Trials in Sepsis

Area of Science:

• Critical Care Medicine
• Clinical Trial Design
• Infectious Diseases

Background:

• Sepsis, a life-threatening organ dysfunction from infection, presents significant treatment development challenges due to patient heterogeneity and knowledge gaps.
• Current sepsis treatment trials often fail to identify effective therapies due to traditional designs and poorly understood parameters like biomarkers and dosing.
• Traditional clinical trial phases are lengthy, delaying the integration of new sepsis treatments into clinical practice.

Purpose of the Study:

• To review the challenges in evaluating sepsis treatments.
• To explore the benefits and weaknesses of adaptive clinical trial designs for sepsis research.
• To discuss how adaptive trials can accelerate the adoption of new sepsis therapies.

Main Methods:

• Review of current literature on sepsis treatment challenges.
• Analysis of traditional clinical trial designs in sepsis.
• Exploration of adaptive clinical trial methodologies and their application to sepsis.

Main Results:

• Sepsis heterogeneity and knowledge gaps hinder traditional treatment development.
• Adaptive trial designs allow simultaneous evaluation of multiple treatments and efficient learning.
• Adaptive trials can be integrated into electronic health records within a learning health system for accelerated adoption.

Conclusions:

• Adaptive clinical trial designs offer a more efficient and effective approach to evaluating sepsis treatments compared to traditional methods.
• Addressing challenges in sepsis treatment evaluation requires innovative trial designs like adaptive methodologies.
• Integrating adaptive trials into learning health systems can expedite the delivery of novel sepsis therapies to patients.